Researchers have introduced a novel method for distinguishing healthy microbiomes from diseased ones based on interactions among gut bacteria, named the Ecological Network Balance Index (ENBI). This tool evaluates whether microbial communities exhibit competition or cooperation, which could have implications for nutrition, metabolic health, and disease resilience. Martin Blaser, M.D., director of Rutgers Health’s Center for Advanced Biotechnology and Medicine, noted that while ENBI effectively differentiates healthy individuals from those with various diseases, such as colorectal cancer, further validation and application are needed before it can be utilized in research and personalized nutrition.
Read More
The study indicates that ENBI can reliably assess health status by analyzing stool samples as disease progresses. It emphasizes that gut health is influenced not just by the types of bacteria present but also by how they interact with each other. This insight suggests a shift in the understanding of gut diseases, opening doors to earlier detection and tailored interventions.
Researchers from Rutgers University, Princeton University, and Spain’s Universidad de Granada developed ENBI through computational simulations. Traditional microbiome analysis often emphasizes diversity, but Blaser argues that understanding the net metabolic interactions—whether the communities are more cooperative or competitive—is crucial. In healthy microbiomes, competition tends to dominate, while dysbiotic communities exhibit cooperative behaviors among bacteria, described as “little mafias” monopolizing resources.
Blaser mentioned that cooperation and competition patterns among microbes might yield deeper insights into diet response and resilience to disease. He stated that ENBI is a research tool that could be applied in nutrition R&D and consumer testing in the future, pending further exploration.
Co-author Maria Gloria Dominguez-Bello pointed out that diseases arise when microbiomes reorganize their structure, forming tightly connected groups that disrupt normal gut function in cases such as inflammatory bowel disease and colorectal cancer. The research revealed that a diverse, competitive microbiome correlates with health, while disease states are marked by small groups of cooperative bacteria.
Senior author Bonachela emphasized the potential for using stool samples as non-invasive monitoring tools for gut health. Blaser reiterated the need for further verification before employing ENBI in personalized nutrition applications.
The team’s research may also shed light on the mixed success of gut health therapies like probiotics and fecal microbiota transplants. Bonachela noted that if treatments focus solely on specific bacteria rather than the relationships between them, the desired outcomes might not be achieved. Introducing whole communities, as in fecal transplants, may preserve beneficial interactions necessary for a healthy microbiome.
Corral López highlighted that matching microbial communities based on interaction networks, rather than just bacterial species, could lead to more effective microbiome-based therapies, moving beyond trial and error.
This new research adds to the growing interest in gut health, with recent studies revealing connections between specific bacteria and various health conditions. A consensus definition of gut health has also been established, describing it as normal gastrointestinal function without debilitating symptoms or disease.